
New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Struggling with early onset dementia, Greg Kelly traveled from Australia to Denmark to see what life would be like in a dementia village. He was surprised by what he saw.

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

Researchers find people living in towns with lots of green space were least likely to have Alzheimer’s or Parkinson’s.

Taking a daily multivitamin supplement can slow age-related memory decline, researchers found.

Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.

Canada’s first dementia village enables its inhabitants to live their lives in freedom and dignity, while ensuring they have person-centered care. Learn more.

Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.

Dementia incidence has steadily fallen by 20 to 25 percent over the past three decades in the U.S., U.K., Sweden, and the Netherlands. How come?

What are the six signs of early dementia, and how can Vitamin B1 help head it off? Dr. Eric Berg explains.

Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.

A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.

Higher midlife omega-3 levels were linked to lower early-onset dementia risk. It’s not proof — but it’s a meaningful signal worth paying attention to.

People with dementia who were consistently seen by the same General Practitioner (GP) are given fewer medicines and are less likely to be given medicines that can cause problems, according to researchers at University of Exeter. Learn more.

A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.

Amyloid is one of the leading culprits behind Alzheimer’s. Scientists know it damages memory by killing brain cells. Now research reveals how amyloid triggers memory loss in perfectly healthy brain cells as well. Learn more about how Alzheimer’s develops.

Getting out into the fresh air and taking a walk does good things for your brain and well-being, researchers say.
No spam, only news and updates.


